PatchTheCVECVE-2022-45611: An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges v
CVE-2022-45611 is a critical-severity flaw (CVSS 9.8) affecting pharmahelp firmware. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Why this priority
- Critical severity
- Remotely exploitable, no login, no user action
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 9.8 (Critical) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | None |
| EPSS exploit chance | 1.2% (top 32%) |
| CISA exploited list | No |
| Weakness | CWE-522 |
| Published | 2023-08-22 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-45611?
pharmahelp firmware: mitigate or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2022-45611 being exploited?
CVE-2022-45611 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-45611 affect?
CVE-2022-45611 affects pharmahelp firmware. Severity is critical (CVSS 9.8). An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
How urgent is CVE-2022-45611?
Priority 56/100. Critical severity; Remotely exploitable, no login, no user action